IMAC HOLDINGS INC. -

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

19 سبتمبر 2024 09:00:00 بحسب Nasdaq GlobeNewswire

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

23 أغسطس 2024 16:20:00 بحسب Nasdaq GlobeNewswire

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

11 يوليو 2024 08:21:00 بحسب Nasdaq GlobeNewswire

IMAC Holdings Announces Leadership Succession

24 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

07 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire